MS Therapy – Gilenya (Fingolimod) Oral Medication

Name: Gilenya (Fingolimod)

Type: Oral Medication
Approved: 2010
Approved For: Reducing the frequency of MS flare-ups (relapses) in patients with Relapsing Remitting Multiple Sclerosis (RRMS) as well as reducing the long term disability effects of MS.
Reported Relapse Reduction Rate: 54% Compared to placebo
Recommended Dosage: 0.5mg orally once daily (with or without food)
Schedule: Daily
Storage: Gilenya capsules should be stored at 77F (25C)
Support Team: Go Program – 1-800-445-3692 – Offers information on paying for medication, information about the first day on medication, forms to start Gilenya, reminders, motivation, and support.

Read more